<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Vesicular, pustular, and bullous lesions in the newborn and infant
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Vesicular, pustular, and bullous lesions in the newborn and infant
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Vesicular, pustular, and bullous lesions in the newborn and infant
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Erin Mathes, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nicole W Kittler, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 22, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vesicles, bullae, and pustules in the newborn may be caused by infections, congenital disorders, or other diseases. Benign and self-limited disorders, including erythema toxicum neonatorum  (
         <a class="graphic graphic_picture graphicRef70785" href="/z/d/graphic/70785.html" rel="external">
          picture 1A
         </a>
         ), transient neonatal pustular melanosis  (
         <a class="graphic graphic_picture graphicRef130729 graphicRef130730 graphicRef59397 graphicRef64567" href="/z/d/graphic/130729.html" rel="external">
          picture 2A-D
         </a>
         ), and neonatal acne  (
         <a class="graphic graphic_picture graphicRef56615" href="/z/d/graphic/56615.html" rel="external">
          picture 3
         </a>
         ), do not require specific therapy. However, certain infections and genetic disorders must be differentiated from these self-limited conditions because treatment may be needed  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Benign pustular eruptions, vesiculopustular eruptions caused by infections, and congenital/inherited bullous diseases presenting in the newborn are reviewed here. Other benign neonatal skin and scalp lesions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/119230.html" rel="external">
          "Skin lesions in the newborn and infant"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H205152040">
         <span class="h1">
          APPROACH TO DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is critical to differentiate transient, benign eruptions of infants and newborns from those that require prompt diagnostic work-up and intervention. The approach to this diagnostic category requires familiarity with the morphology, timing, and course of common presentations that affect newborns and infants so that one can distinguish them from rarer, more serious conditions. In addition, knowledge of risk factors, exposures, and family history can also help narrow the differential diagnosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A thorough clinical history and physical examination in most cases provide important clues for diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The possibility of a viral, bacterial, or fungal infection should always be considered.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vesicular lesions following the lines of Blaschko on a newborn infant suggest the possibility of incontinentia pigmenti, a rare, X-linked dominant disorder  (
         <a class="graphic graphic_picture graphicRef58769" href="/z/d/graphic/58769.html" rel="external">
          picture 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An erosive patch or blister-like lesion on the scalp or another area of the body at birth may occur due to a local absence of skin called aplasia cutis congenita  (
         <a class="graphic graphic_picture graphicRef89935" href="/z/d/graphic/89935.html" rel="external">
          picture 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Features that suggest a potentially severe or life-threatening disease include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Widespread erythema and blistering
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vital sign abnormalities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Associated anomalies
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor growth
        </p>
        <p>
        </p>
        <p>
         In such cases, diagnostic testing should be pursued, and the infant should be closely monitored when there is uncertainty and when infectious, severe, or life-threatening etiologies are on the differential diagnosis in a young infant.
        </p>
        <p class="headingAnchor" id="H3515631829">
         <span class="h1">
          BENIGN VESICULOPUSTULAR ERUPTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although most vesiculopustular eruptions in newborns are benign and self-limiting, the differential diagnosis includes conditions that require prompt recognition and treatment  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H2228646118">
         <span class="h2">
          Generalized
         </span>
        </p>
        <p class="headingAnchor" id="H3426440751">
         <span class="h3">
          Erythema toxicum neonatorum
         </span>
         <span class="headingEndMark">
          —
         </span>
         Erythema toxicum neonatorum is a common, pustular disorder occurring in approximately 20 percent of neonates in the first 72 hours of life [
         <a href="#rid1">
          1-4
         </a>
         ]. It occurs more frequently in neonates with higher birth weight and greater gestational age. The etiology is unknown. One hypothesis is that erythema toxicum neonatorum represents an acute, innate immune response to the penetration of skin-colonizing flora into the hair follicle [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Erythema toxicum neonatorum presents with multiple erythematous macules and papules (1 to 3 mm in diameter) that rapidly progress to pustules on an erythematous base  (
         <a class="graphic graphic_picture graphicRef70785 graphicRef130733 graphicRef78577" href="/z/d/graphic/70785.html" rel="external">
          picture 1A-C
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ]. The lesions are distributed over the trunk and proximal extremities, sparing the palms and soles. They may be present at birth but typically appear within 24 to 48 hours. The rash usually resolves in five to seven days, although it may wax and wane before complete resolution [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of erythema toxicum neonatorum is usually made based on the clinical appearance. It can be confirmed by microscopic examination of a Wright-stained smear of the contents of a pustule that demonstrates numerous eosinophils and occasional neutrophils (see
         <a class="medical medical_review" href="/z/d/html/4435.html" rel="external">
          "Evaluation of the peripheral blood smear", section on 'Slide preparation'
         </a>
         ). However, this is usually not necessary. A minority of patients (7 to 18 percent) may also have peripheral eosinophilia [
         <a href="#rid8">
          8
         </a>
         ]. If the presentation is atypical, cultures of the pustule contents for bacteria, fungi, and viruses should be obtained  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ). These are all negative in erythema toxicum neonatorum.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – Erythema toxicum neonatorum resolves spontaneously. No treatment is necessary.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1971323542">
         <span class="h3">
          Transient neonatal pustular melanosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transient neonatal pustular melanosis is less common than erythema toxicum neonatorum. It mostly affects full-term Black infants and infants with darkly pigmented skin, although it is described in all ethnic groups [
         <a href="#rid4">
          4,9
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Transient neonatal pustular melanosis consists of three types of lesions [
         <a href="#rid10">
          10
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small pustules on a nonerythematous base. These are usually present at birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pink-red to brown-black macules with a surrounding collarette of scale  (
         <a class="graphic graphic_picture graphicRef64567 graphicRef130729" href="/z/d/graphic/64567.html" rel="external">
          picture 2A, 2D
         </a>
         ). These develop as the pustules rupture and may persist for weeks to months.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Brown-black macules that gradually fade over several weeks to months  (
         <a class="graphic graphic_picture graphicRef59397 graphicRef130730" href="/z/d/graphic/59397.html" rel="external">
          picture 2B-C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Lesions in different stages may be present at the same time (even at birth) [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of transient neonatal pustular melanosis is usually based upon the clinical appearance. Microscopic examination of a Wright-stained smear of the contents of a pustule demonstrates numerous neutrophils and, in contrast with erythema toxicum neonatorum, rare eosinophils. However, this is not usually necessary. Culture, if performed, yields no organism.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – No treatment is necessary.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3315746990">
         <span class="h3">
          Miliaria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Miliaria is a common, transient, vesiculopapular disorder of newborns, especially in warm climates, caused by accumulation of sweat in obstructed eccrine sweat ducts [
         <a href="#rid11">
          11-13
         </a>
         ].
        </p>
        <p>
         Depending on the level of sweat duct obstruction, miliaria presents clinically as miliaria crystallina  (
         <a class="graphic graphic_picture graphicRef55627" href="/z/d/graphic/55627.html" rel="external">
          picture 6
         </a>
         ), miliaria rubra (also called "heat rash" or "prickly heat"  (
         <a class="graphic graphic_picture graphicRef102865 graphicRef102847" href="/z/d/graphic/102865.html" rel="external">
          picture 7A-B
         </a>
         )), and miliaria profunda.
        </p>
        <p>
         The diagnosis is usually clinical. No specific treatment is needed. Lesions usually resolve rapidly when the infant is placed in a cooler environment with associated measures to reduce sweating, such as light, loose clothing, and cool baths.
        </p>
        <p>
         Miliaria is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13733.html" rel="external">
          "Miliaria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3595187590">
         <span class="h2">
          Localized
         </span>
        </p>
        <p class="headingAnchor" id="H480811413">
         <span class="h3">
          Eosinophilic pustular folliculitis of infancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Eosinophilic pustular folliculitis of infancy is an uncommon dermatosis of unknown etiology occurring in newborns and infants. Its relationship with the adult eosinophilic pustular folliculitis (Ofuji disease) is uncertain.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Eosinophilic pustular folliculitis of infancy presents with recurrent crops of pruritic, follicular pustules, most commonly on the scalp  (
         <a class="graphic graphic_picture graphicRef115760" href="/z/d/graphic/115760.html" rel="external">
          picture 8
         </a>
         ) but also on the extremities  (
         <a class="graphic graphic_picture graphicRef115761" href="/z/d/graphic/115761.html" rel="external">
          picture 9
         </a>
         ). In a retrospective study of 61 cases of eosinophilic pustular folliculitis of infancy, the median age of onset was five months, with a male-to-female ratio of 4:1 [
         <a href="#rid14">
          14
         </a>
         ]. Tissue eosinophilia is a universal finding and can be demonstrated by smear or biopsy. Some infants also have blood eosinophilia. Recurrence is the rule, with outbreaks occurring at intervals of 1 to 12 weeks and resolving in one to four weeks. Complete resolution occurs by age 3 in most children [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis is based upon clinical features, course, and the demonstration of eosinophils in pustule content or in skin biopsy. The differential diagnosis includes erythema toxicum neonatorum, transient neonatal pustular melanosis, infantile acropustulosis, herpes simplex infection, and impetigo.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Treatment is symptomatic. Topical corticosteroids appear to be effective in hastening the lesions' resolution and controlling pruritus [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4121463882">
         <span class="h3">
          Neonatal cephalic pustulosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal cephalic pustulosis (previously called "neonatal acne") is a common eruption that occurs in approximately 20 percent of infants. This eruption is believed to be an inflammatory reaction to skin colonization with
         <em>
          Malassezia
         </em>
         species [
         <a href="#rid15">
          15,16
         </a>
         ], although one series found no difference in the prevalence of
         <em>
          Malassezia
         </em>
         colonization between neonates with cephalic pustulosis and neonates without it [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Neonatal cephalic pustulosis is a separate entity from true infantile acne [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">
          "Acne in infants, young children, and preadolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – The mean age at onset is three weeks [
         <a href="#rid19">
          19
         </a>
         ]. The presence of inflammatory papules and pustules, the absence of comedones, and the characteristic distribution limited to the face (especially the cheeks) and sometimes the scalp are diagnostic in most cases  (
         <a class="graphic graphic_picture graphicRef115785" href="/z/d/graphic/115785.html" rel="external">
          picture 10
         </a>
         ). Neonatal cephalic pustulosis may appear very similar to miliaria rubra  (
         <a class="graphic graphic_picture graphicRef115786 graphicRef115787" href="/z/d/graphic/115786.html" rel="external">
          picture 11A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13733.html" rel="external">
          "Miliaria"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – In the majority of cases, neonatal cephalic pustulosis is mild and can be treated with daily cleansing with soap and water and avoidance of exogenous oils and lotions [
         <a href="#rid20">
          20
         </a>
         ]. The eruption usually resolves spontaneously within four months without scarring [
         <a href="#rid20">
          20
         </a>
         ]. Application of 2%
         <a class="drug drug_pediatric" data-topicid="13401" href="/z/d/drug information/13401.html" rel="external">
          ketoconazole
         </a>
         cream twice daily or 1%
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         cream once daily may expedite clearance of lesions [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3098968329">
         <span class="h3">
          Infantile acne
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infantile acne is an uncommon and distinct entity from neonatal cephalic pustulosis. It typically presents at the age of 6 to 16 months  (
         <a class="graphic graphic_picture graphicRef115789 graphicRef115788" href="/z/d/graphic/115789.html" rel="external">
          picture 12A-B
         </a>
         ) [
         <a href="#rid22">
          22
         </a>
         ]. Infantile acne is caused by a prolonged, physiologic, and transient increase in the levels of adrenal androgens, which usually normalize around the age of six months [
         <a href="#rid13">
          13,23
         </a>
         ]. It presents with typical, acneiform lesions, including comedones, inflammatory papules, pustules, and sometimes nodules on the face  (
         <a class="graphic graphic_picture graphicRef115788 graphicRef115789" href="/z/d/graphic/115788.html" rel="external">
          picture 12A-B
         </a>
         ) [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         The pathogenesis, clinical presentation, and management of infantile acne are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">
          "Acne in infants, young children, and preadolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H416223681">
         <span class="h3">
          Infantile acropustulosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infantile acropustulosis is an uncommon, vesiculopustular disorder that often has a more chronic course than other benign neonatal eruptions.
        </p>
        <p>
         The etiology is unknown. A nonspecific hypersensitivity reaction to scabies has been postulated because many patients have been treated for scabies before being diagnosed with infantile acropustulosis, but this association remains unproven [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Infantile acropustulosis is characterized by recurrent crops of intensely pruritic vesiculopustules, mainly on the palms and soles  (
         <a class="graphic graphic_picture graphicRef115791 graphicRef77411" href="/z/d/graphic/115791.html" rel="external">
          picture 13A-B
         </a>
         ) but sometimes involving the dorsal aspect of the hands and feet and the limbs  (
         <a class="graphic graphic_picture graphicRef55499 graphicRef115792" href="/z/d/graphic/55499.html" rel="external">
          picture 14A-B
         </a>
         ). It may be present at birth or, more commonly, have onset any time during the first year of life. Recurrences generally occur every two to four weeks and may last 5 to 10 days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of infantile acropustulosis is based upon clinical features. Because of the association with scabies, skin scrapings should be examined [
         <a href="#rid25">
          25,26
         </a>
         ]. Skin biopsy is not usually necessary but, if performed, demonstrates a subcorneal pustule filled with neutrophils and eosinophils [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The differential diagnosis of infantile acropustulosis includes dyshidrotic eczema, pustular psoriasis, erythema toxicum neonatorum, transient neonatal pustular melanosis, eosinophilic pustular folliculitis of infancy, scabies, and impetigo  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13657.html" rel="external">
          "Acute palmoplantar eczema (dyshidrotic eczema)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89271.html" rel="external">
          "Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="local">
          'Erythema toxicum neonatorum'
         </a>
         above and
         <a class="local">
          'Transient neonatal pustular melanosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Infantile acropustulosis typically resolves spontaneously within two years. Mid- to high-potency topical corticosteroids (groups 1 to 4  (
         <a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">
          table 2
         </a>
         )) are the first-line treatment for flares of infantile acropustulosis [
         <a href="#rid25">
          25,28
         </a>
         ]. Systemic absorption of topical corticosteroids in infantile acropustulosis is limited by the localized distribution of the lesions, the thickness of skin in the affected (acral) areas, and the periodicity of the flares [
         <a href="#rid6">
          6,25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5565.html" rel="external">
          "Topical corticosteroids: Use and adverse effects", section on 'Use in children'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other treatments that have been reported as effective for infantile acropustulosis include oral antihistamines, oral
         <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">
          erythromycin
         </a>
         , and oral
         <a class="drug drug_pediatric" data-topicid="13205" href="/z/d/drug information/13205.html" rel="external">
          dapsone
         </a>
         for several months duration [
         <a href="#rid25">
          25,27-32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although
         <a class="drug drug_pediatric" data-topicid="13205" href="/z/d/drug information/13205.html" rel="external">
          dapsone
         </a>
         is reliably effective, its potentially serious adverse effects limit its use [
         <a href="#rid25">
          25
         </a>
         ]. Oral dapsone (1 to 2 mg/kg per day) should thus be reserved for severe, recalcitrant cases. Adverse effects of dapsone may include peripheral neuropathy, aplastic anemia, hepatitis, hemolytic anemia, and methemoglobinemia [
         <a href="#rid25">
          25
         </a>
         ]. A glucose-6-phosphate dehydrogenase (G6PD) screening should be done before starting dapsone. (See
         <a class="medical medical_review" href="/z/d/html/7111.html" rel="external">
          "Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Oral
         <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">
          erythromycin
         </a>
         (10 mg/kg/dose every six hours) or oral antihistamines are alternatives to topical corticosteroids. Erythromycin appears to have an anti-inflammatory effect. Antihistamines are effective in relieving pruritus but only in high doses, suggesting that sedation is necessary for efficacy [
         <a href="#rid25">
          25,30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H799739628">
         <span class="h3">
          Vesiculopustular eruption and transient myeloproliferative disorder in Down syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 20 percent of newborns with Down syndrome present with transient myeloproliferative disorder (also called transient leukemia) [
         <a href="#rid33">
          33-35
         </a>
         ]. In rare instances, transient myeloproliferative disorder is accompanied by a vesiculopustular eruption predominantly located on the face that begins during the first few days of life. The examination of a skin biopsy shows intraepidermal, spongiotic vesiculopustules and a perivascular infiltrate containing immature myeloid cells, which are also usually present in the peripheral blood. The skin lesions resolve spontaneously in one to three months, as the transient myeloproliferative disorder regresses. (See
         <a class="medical medical_review" href="/z/d/html/2917.html" rel="external">
          "Down syndrome: Clinical features and diagnosis", section on 'Transient myeloproliferative disorder'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INFECTIOUS VESICULOPUSTULAR ERUPTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection should always be considered as a cause of vesiculobullous or pustular lesions in the newborn [
         <a href="#rid36">
          36
         </a>
         ]. Infectious disorders may be life threatening and require urgent therapeutic intervention. The clinical features of the most common infectious vesiculopustular eruptions in newborns are summarized in the table  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Viral infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of viruses can cause vesiculopustular or bullous lesions in the newborn. In most cases, lesions do not appear at birth but rather days to weeks later. Herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most common etiologic agents, but cytomegalovirus and coxsackievirus can also occasionally be causative. (See
         <a class="medical medical_review" href="/z/d/html/5965.html" rel="external">
          "Overview of cytomegalovirus infections in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Neonatal herpes simplex virus infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal HSV infection is rare. It primarily results from intrapartum exposure to maternal cervical or vaginal lesions or by an ascending infection, sometimes through apparently intact membranes [
         <a href="#rid37">
          37
         </a>
         ]. Postnatal inoculation may also occur but is less common [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Symptoms can develop within days to four weeks after birth. HSV infection in newborns usually develops in one of three patterns:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized to the skin, eyes, and mouth (SEM disease)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized central nervous system disease
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Disseminated disease involving multiple organs
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Skin lesions occur in the majority of patients and may be present in all three infection patterns [
         <a href="#rid38">
          38
         </a>
         ]. They are not usually present at birth and develop at 6 to 13 days of age [
         <a href="#rid13">
          13
         </a>
         ]. Infants with lesions at birth (congenital HSV infection) have intrauterine, rather than perinatal, infection and are also usually premature.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The skin lesions typically consist of clusters of 1 to 3 mm vesicles and erythematous papules that may develop into pustules, crusts, and erosions  (
         <a class="graphic graphic_picture graphicRef75059" href="/z/d/graphic/75059.html" rel="external">
          picture 15
         </a>
         ). They usually occur on the scalp  (
         <a class="graphic graphic_picture graphicRef115776" href="/z/d/graphic/115776.html" rel="external">
          picture 16
         </a>
         ), sometimes associated with placement of a fetal monitor electrode, or face  (
         <a class="graphic graphic_picture graphicRef115777" href="/z/d/graphic/115777.html" rel="external">
          picture 17
         </a>
         ) [
         <a href="#rid13">
          13
         </a>
         ]. Lesions also may occur on the trunk  (
         <a class="graphic graphic_picture graphicRef115778" href="/z/d/graphic/115778.html" rel="external">
          picture 18
         </a>
         ) or buttocks (especially with a breech presentation). When lesions are present at birth, they usually appear as superficial erosions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Newborns with disseminated disease often present in the first week of life with nonspecific signs and symptoms of sepsis (eg, temperature dysregulation, lethargy, respiratory distress, abdominal distension, hepatomegaly, ascites). Central nervous system disease presents with fever, lethargy, and focal seizures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of neonatal HSV is confirmed through isolation of HSV from multiple specimens (eg, swabs/scrapings/aspirate of vesicle fluid; mucosal swabs of conjunctivae, mouth, nasopharynx, and rectum; cerebrospinal fluid; blood or plasma) by viral culture, polymerase chain reaction, direct immunofluorescence assays, or enzyme immunoassays. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Tests to confirm the diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Neonatal HSV infection should be distinguished from other vesiculopustular disorders  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ), such as congenital cutaneous candidiasis  (
         <a class="graphic graphic_picture graphicRef94975" href="/z/d/graphic/94975.html" rel="external">
          picture 26B
         </a>
         ), transient neonatal pustular melanosis  (
         <a class="graphic graphic_picture graphicRef59397 graphicRef64567" href="/z/d/graphic/59397.html" rel="external">
          picture 2C-D
         </a>
         ), and incontinentia pigmenti  (
         <a class="graphic graphic_picture graphicRef58769" href="/z/d/graphic/58769.html" rel="external">
          picture 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/89273.html" rel="external">
          "Erythroderma in children", section on 'Congenital cutaneous candidiasis'
         </a>
         and
         <a class="local">
          'Transient neonatal pustular melanosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">
          "Incontinentia pigmenti"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Neonatal HSV infection is treated with intravenous
         <a class="drug drug_pediatric" data-topicid="13247" href="/z/d/drug information/13247.html" rel="external">
          acyclovir
         </a>
         and supportive measures [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The clinical presentation, diagnosis, and management of neonatal HSV infection are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Neonatal varicella-zoster virus infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perinatally acquired varicella is a rare and serious illness associated with a mortality rate of up to 20 percent [
         <a href="#rid40">
          40
         </a>
         ]. Newborns born to mothers who are exposed to VZV or have clinical disease manifestations within two weeks of delivery are at the greatest risk for infection. If the mother develops the rash between five days before and two days after delivery, the newborn is likely to develop a generalized and potentially fatal infection [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Neonatal varicella presents with fever in the first week of life, followed by the development of a cutaneous, macular eruption that rapidly progresses to papules and then to characteristic, vesicular lesions before crusting. It usually first appears on the head and then generalizes  (
         <a class="graphic graphic_picture graphicRef115779" href="/z/d/graphic/115779.html" rel="external">
          picture 19
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of neonatal varicella is often made clinically, based on the characteristic appearance of the cutaneous eruption in various stages of development in a newborn born to a mother exposed to VZV or with clinical symptoms of varicella close to the time of delivery. The diagnosis can be confirmed by detection of the virus using polymerase chain reaction. (See
         <a class="medical medical_review" href="/z/d/html/8329.html" rel="external">
          "Diagnosis of varicella-zoster virus infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Newborns with VZV infection are treated with intravenous
         <a class="drug drug_pediatric" data-topicid="13247" href="/z/d/drug information/13247.html" rel="external">
          acyclovir
         </a>
         [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The clinical presentation, diagnosis, and management of VZV infection in the newborn are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4969.html" rel="external">
          "Varicella-zoster infection in the newborn"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3412492525">
         <span class="h3">
          Monkeypox virus infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Monkeypox virus infection (mpox) in infants during the 2022 global outbreak is uncommon [
         <a href="#rid43">
          43
         </a>
         ]. However, mpox should be considered in the differential diagnosis of an infant presenting with a febrile illness and a vesicular or pustular skin eruption. Based on the descriptions of a few reported cases [
         <a href="#rid44">
          44,45
         </a>
         ], mpox in infants initially presents with erythematous, macular lesions evolving in a few days to papules, vesicles, and pustules that may involve the whole skin surface (including the face, palms, and soles). In one case report of a severely ill newborn with mpox and concurrent adenovirus infection, the infant improved after receiving oral
         <a class="drug drug_pediatric" data-topicid="118596" href="/z/d/drug information/118596.html" rel="external">
          tecovirimat
         </a>
         and intravenous
         <a class="drug drug_pediatric" data-topicid="13155" href="/z/d/drug information/13155.html" rel="external">
          cidofovir
         </a>
         [
         <a href="#rid44">
          44
         </a>
         ]. In another case, the infant was treated with oral tecovirimat and
         <a class="drug drug_pediatric" data-topicid="139320" href="/z/d/drug information/139320.html" rel="external">
          vaccinia immune globulin
         </a>
         intravenous [
         <a href="#rid45">
          45
         </a>
         ]. However, the safety and benefit of vaccinia immune globulin intravenous in children have not been established. All cases were acquired from close household contacts. (See
         <a class="medical medical_review" href="/z/d/html/139254.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of mpox (monkeypox)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8295.html" rel="external">
          "Treatment and prevention of mpox (monkeypox)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Bacterial infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial infection in neonates may present with vesiculobullous or pustular lesions. The most common pathogen causing skin and soft tissue infections in neonates is
         <em>
          Staphylococcus aureus
         </em>
         . Sepsis caused by
         <em>
          Listeria monocytogenes
         </em>
         ,
         <em>
          Streptococcus
         </em>
         species, or
         <em>
          Pseudomonas aeruginosa
         </em>
         can have associated skin lesions, as can
         <em>
          Treponema pallidum
         </em>
         infection  (
         <a class="graphic graphic_table graphicRef75417" href="/z/d/graphic/75417.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Staphylococcal pustulosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In newborns, cutaneous staphylococcal infection usually presents with localized, superficial, vesicular, pustular, or bullous lesions on an erythematous base  (
         <a class="graphic graphic_picture graphicRef107272" href="/z/d/graphic/107272.html" rel="external">
          picture 20
         </a>
         ). Vesicles and bullae are easily ruptured, resulting in superficial erosions and honey-colored crusts. Lesions are usually found in areas of trauma, such as the diaper area, circumcision wound, axillae, and periumbilical skin, although they may appear anywhere on the body.
        </p>
        <p>
         The diagnosis is confirmed with demonstration of gram-positive cocci in clusters and neutrophils on a Gram stain of the pustular fluid and isolation of
         <em>
          S. aureus
         </em>
         on culture. If the lesions are extensive or the infant appears ill, a blood culture should be obtained prior to starting treatment.
        </p>
        <p>
         The evaluation and treatment  (
         <a class="graphic graphic_algorithm graphicRef113285" href="/z/d/graphic/113285.html" rel="external">
          algorithm 1
         </a>
         ) of
         <em>
          S. aureus
         </em>
         and streptococcal skin and soft tissue infection in the newborn are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/106447.html" rel="external">
          "Skin and soft tissue infections in neonates: Evaluation and management", section on 'Antimicrobial therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Staphylococcal scalded skin syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Newborns are susceptible to hematogenous dissemination of
         <em>
          S. aureus
         </em>
         exfoliative toxins, resulting in staphylococcal scalded skin syndrome (SSSS; or Ritter disease) [
         <a href="#rid46">
          46
         </a>
         ]. Hospital outbreaks have been reported [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         The two pathogenic toxins produced in SSSS are exfoliative (or epidermolytic) toxin A and exfoliative toxin B. They act as serine protease enzymes in the stratum granulosum that cleave desmoglein 1, an important desmosomal protein responsible for keratinocyte-to-keratinocyte adhesion [
         <a href="#rid48">
          48
         </a>
         ]. This results in the formation of fragile, flaccid bullae that easily rupture in areas of friction, resulting in superficial erosions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Presentation usually occurs at three to seven days of age and is rarely seen at birth [
         <a href="#rid13">
          13
         </a>
         ]. Affected infants are febrile and irritable, with diffuse, blanching erythema often beginning around the mouth. Flaccid blisters appear one to two days later, especially in areas of mechanical stress, including flexural areas, buttocks, hands, and feet. Gentle pressure applied to the skin results in separation of the upper epidermis and wrinkling of the skin (Nikolsky's sign). In some cases, the entire upper epidermis may be shed  (
         <a class="graphic graphic_picture graphicRef72261" href="/z/d/graphic/72261.html" rel="external">
          picture 21A
         </a>
         and
         <a class="graphic graphic_picture graphicRef121041" href="/z/d/graphic/121041.html" rel="external">
          picture 21B
         </a>
         ) [
         <a href="#rid13">
          13
         </a>
         ]. Affected infants often have conjunctivitis; mucous membranes are not involved but may appear hyperemic.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Superficial desquamation occurs as the lesions heal [
         <a href="#rid13">
          13
         </a>
         ]. Because the cleavage plane of the blisters is intraepidermal, scars do not occur.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – If SSSS is suspected, cultures should be obtained from blood, urine, nasopharynx, umbilicus, abnormal skin, or any suspected focus of infection. The intact bullae are sterile. Diagnosis is usually clinical, although it may be confirmed with skin biopsy that shows a cleavage plane in the lower stratum granulosum with minimal necrosis [
         <a href="#rid49">
          49
         </a>
         ]. However, biopsy is rarely required. The microscopic examination may be performed on a frozen section to expedite treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – SSSS should be differentiated from toxic epidermal necrolysis (TEN), which is more commonly seen in older children as a reaction to drugs or infections [
         <a href="#rid50">
          50
         </a>
         ]. On histopathologic examination, TEN reveals a subepidermal cleavage plane and full-thickness epidermal necrosis. Additionally, unlike SSSS, the involvement of mucous membranes is a frequent clinical feature of TEN. (See
         <a class="medical medical_review" href="/z/d/html/2091.html" rel="external">
          "Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Newborns with SSSS are treated in an inpatient setting. Seriously ill children should be admitted to an intensive care unit or burn unit. Treatment with intravenous penicillinase-resistant penicillin, such as
         <a class="drug drug_pediatric" data-topicid="12626" href="/z/d/drug information/12626.html" rel="external">
          nafcillin
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12663" href="/z/d/drug information/12663.html" rel="external">
          oxacillin
         </a>
         , should be promptly initiated.
         <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">
          Vancomycin
         </a>
         should be considered in areas with a high prevalence of community-acquired methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (CA-MRSA) or for patients who fail to respond to initial therapy  (
         <a class="graphic graphic_table graphicRef64140" href="/z/d/graphic/64140.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid51">
          51,52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6057.html" rel="external">
          "
          <i>
           Staphylococcus aureus
          </i>
          in children: Overview of treatment of invasive infections", section on 'Treatment of neonates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Supportive care involves replacement of fluid and electrolyte losses and gentle skin care with petroleum jelly and nonadherent dressings.
        </p>
        <p>
        </p>
        <p>
         SSSS is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/114922.html" rel="external">
          "Staphylococcal scalded skin syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Streptococcal infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Streptococcal skin infections from group A or, rarely, group B
         <em>
          Streptococcus
         </em>
         may mimic those caused by
         <em>
          S. aureus
         </em>
         , although they are less common. Affected newborns may present with pustules and honey-colored crusts, often in association with a moist umbilical cord stump or omphalitis [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         The diagnosis is confirmed with demonstration of gram-positive cocci in chains on Gram stain of the pustular fluid and isolation of
         <em>
          Streptococcus
         </em>
         in culture.
        </p>
        <p>
         Pending the culture results, empiric therapy with intravenous
         <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">
          ampicillin
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">
          gentamicin
         </a>
         , which provides broad coverage for group B and other streptococci, some gram-negative enteric organisms, and
         <em>
          L. monocytogenes
         </em>
         , should be administered. Once
         <em>
          Streptococcus
         </em>
         is identified as the sole causative organism, the therapy can be changed to
         <a class="drug drug_pediatric" data-topicid="12687" href="/z/d/drug information/12687.html" rel="external">
          penicillin G
         </a>
         alone  (
         <a class="graphic graphic_table graphicRef66906" href="/z/d/graphic/66906.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">
          "Group B streptococcal infection in neonates and young infants", section on 'Antimicrobial therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Listeriosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infections from
         <em>
          L. monocytogenes
         </em>
         can occur in newborns [
         <a href="#rid54">
          54
         </a>
         ]. Clinical manifestations can occur early (before seven days) or late (after seven days). Both forms can present with meningitis and signs of septicemia. Infants with the early form often have multiple pustules on the skin and mucous membranes [
         <a href="#rid55">
          55,56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1277.html" rel="external">
          "Clinical manifestations and diagnosis of Listeria monocytogenes infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Congenital syphilis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital syphilis occurs when
         <em>
          T. pallidum
         </em>
         is transmitted from a pregnant woman to her fetus. It should always be included in the differential diagnosis of a newborn with blisters or erosions, especially when present at birth. The incidence has risen markedly in the past several years [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis", section on 'Early congenital syphilis'
         </a>
         .)
        </p>
        <p>
         Early manifestations can be quite variable. Infants may be normal at birth and become symptomatic during the first five weeks of life. Hemorrhagic vesicles or bullae and petechiae that start on the palms and soles and spread to the trunk and extremities are nearly pathognomonic of congenital syphilis  (
         <a class="graphic graphic_picture graphicRef115793 graphicRef81352" href="/z/d/graphic/115793.html" rel="external">
          picture 22A-B
         </a>
         ). If ulcerative in nature, they are highly contagious. A more common presentation is a papulosquamous eruption similar to the exanthem of secondary syphilis in adults  (
         <a class="graphic graphic_picture graphicRef115794" href="/z/d/graphic/115794.html" rel="external">
          picture 23
         </a>
         ) or a desquamative dermatitis also involving the palms and soles. Other early manifestations include rhinitis (snuffles), anemia, thrombocytopenia, lymphadenopathy, hepatomegaly, fever, and poor feeding [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         The diagnosis and treatment of congenital syphilis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15400.html" rel="external">
          "Congenital syphilis: Management and outcome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Fungal infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Candida albicans
         </em>
         infections are common in the neonatal period and are usually benign. Case reports have been published of
         <em>
          Aspergillus
         </em>
         species causing vesicular lesions in very low birth weight newborns [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Mucocutaneous candidiasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Candida
         </em>
         infection in the neonate usually develops after the first week of life. It is most likely to affect moist, warm regions and skin folds (eg, in the diaper area) or mucous membranes in the mouth (where it is known as thrush). Candidal diaper dermatitis characteristically appears as an erythematous eruption in the inguinal region. The rash classically has areas of confluent erythema with multiple tiny pustules or discrete, erythematous papules and plaques with superficial scale  (
         <a class="graphic graphic_picture graphicRef115796" href="/z/d/graphic/115796.html" rel="external">
          picture 24
         </a>
         ). Satellite lesions are typically noted  (
         <a class="graphic graphic_picture graphicRef115797 graphicRef59361" href="/z/d/graphic/115797.html" rel="external">
          picture 25A-B
         </a>
         ). Topical treatment is adequate in most cases, as dissemination is rare. (See
         <a class="medical medical_review" href="/z/d/html/5795.html" rel="external">
          "Diaper dermatitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Congenital cutaneous candidiasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital cutaneous candidiasis is a rare disorder that results from a
         <em>
          Candida
         </em>
         spp infection acquired in utero or during delivery. It presents at birth or in the first few days of life with small, diffuse, erythematous macules and pustules, often involving the palms and soles  (
         <a class="graphic graphic_picture graphicRef118658 graphicRef94975" href="/z/d/graphic/118658.html" rel="external">
          picture 26A-B
         </a>
         ). The clinical manifestations and treatment of congenital candidiasis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">
          "Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Congenital candidiasis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5029.html" rel="external">
          "Treatment of Candida infection in neonates"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2649463040">
         <span class="h2">
          Infestations
         </span>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Scabies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Scabies is a relatively uncommon cause of pustular eruption in the newborn in resource-abundant regions but may be more common in resource-limited regions [
         <a href="#rid61">
          61
         </a>
         ]. Scabies is caused by infestation with the
         <em>
          Sarcoptes scabiei
         </em>
         mite. The skin eruption results from a hypersensitivity reaction to the proteins of the female parasite, which burrows into the upper layers of the epidermis [
         <a href="#rid62">
          62
         </a>
         ]. Transmission of scabies is usually from person to person by direct contact. (See
         <a class="medical medical_review" href="/z/d/html/4038.html" rel="external">
          "Scabies: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Scabies may present as early as three to four weeks of age, the earliest time infants can develop hypersensitivity to the mites, but is never present at birth. The characteristic appearance is of erythematous papules that are intensely pruritic. Infants are more likely than older children to develop vesicles, pustules, nodules, and crusting [
         <a href="#rid63">
          63
         </a>
         ]. The involvement can be localized initially, but then it becomes widespread and often affects the hands, feet, and wrists, which usually are spared in older children and adults  (
         <a class="graphic graphic_picture graphicRef115804" href="/z/d/graphic/115804.html" rel="external">
          picture 27A
         </a>
         ) [
         <a href="#rid64">
          64
         </a>
         ]. The face may be involved because of contact with infested maternal skin while breastfeeding. Infants may manifest poor feeding, fussiness, and failure to thrive, presumably because of the intense pruritus, or be asymptomatic [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis should be considered in an infant with a vesiculopustular eruption that involves the palms and, especially, the soles  (
         <a class="graphic graphic_picture graphicRef76789" href="/z/d/graphic/76789.html" rel="external">
          picture 28
         </a>
         ). The combination of a pruritic eruption, characteristic distribution, and household involvement is usually enough to establish a diagnosis. Mites or eggs can be demonstrated in scrapings from burrows or papules [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4038.html" rel="external">
          "Scabies: Epidemiology, clinical features, and diagnosis", section on 'Scabies preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Scabies is often confused with infantile acropustulosis, insect bites, impetigo, atopic dermatitis, or urticaria pigmentosa.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – The infant, all the household, and close contacts should be treated simultaneously, and environmental decontamination should also be performed. Treatment consists of one application of
         <a class="drug drug_pediatric" data-topicid="12696" href="/z/d/drug information/12696.html" rel="external">
          permethrin
         </a>
         5% cream at bedtime to all skin surfaces in infants (not approved for infants younger than two months) [
         <a href="#rid66">
          66
         </a>
         ] and from the neck down in older household contacts. It should be washed off after 8 to 14 hours [
         <a href="#rid61">
          61
         </a>
         ]. Repeated applications may be needed, as the failure rate is significant [
         <a href="#rid67">
          67
         </a>
         ]. An alternative therapy for newborns is the application of 5 to 10% precipitated sulfur in petrolatum. (See
         <a class="medical medical_review" href="/z/d/html/114369.html" rel="external">
          "Scabies: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          CONGENITAL/INHERITED DISORDERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several uncommon congenital or inherited conditions may present with bullous lesions in the newborn.
        </p>
        <p class="headingAnchor" id="H1065231708">
         <span class="h2">
          Sucking blisters
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital sucking blisters, a diagnosis of exclusion, are noninflammatory, oval, thick-walled vesicles or bullae that contain sterile fluid [
         <a href="#rid68">
          68
         </a>
         ]. The lesions may be unilateral or bilateral and are typically located on the dorsal or radial aspect of the wrists, hands, or fingers of neonates who are noted to suck excessively at the involved regions  (
         <a class="graphic graphic_picture graphicRef78479" href="/z/d/graphic/78479.html" rel="external">
          picture 29
         </a>
         ).
        </p>
        <p>
         The differential diagnosis of sucking blisters includes herpes simplex virus infection, bullous impetigo, congenital syphilis or candidiasis, neonatal lupus erythematosus, and hereditary bullous diseases [
         <a href="#rid68">
          68
         </a>
         ]. These disorders are usually, but not always, accompanied by additional clinical signs or suggestive maternal history.
        </p>
        <p>
         Observation of the neonate's sucking on the involved areas is the most helpful clue to the correct diagnosis of congenital sucking blisters. Other suggestive features include the absence of lesions in other areas, well appearance of the infant, and rapid resolution of the lesions.
        </p>
        <p class="headingAnchor" id="H406662009">
         <span class="h3">
          Congenital erosive and vesicular dermatosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital erosive and vesicular dermatosis (CEVD) is a rare condition presenting in the neonate with erythema, vesicles, erosions, ulcerations, and crusting predominantly involving the trunk and limbs that heal in the first few months of life with reticulate supple scarring [
         <a href="#rid69">
          69,70
         </a>
         ]. The affected newborns are often premature. The pathogenesis of CEVD is unknown. Some cases have been associated with intrauterine herpes virus or fungal infections [
         <a href="#rid71">
          71,72
         </a>
         ]. However, the role of infection in the pathogenesis of CEVD remains unclear.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Epidermolysis bullosa
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermolysis bullosa is a group of inherited diseases characterized by skin fragility and blister formation caused by minor skin trauma  (
         <a class="graphic graphic_picture graphicRef86267" href="/z/d/graphic/86267.html" rel="external">
          picture 30
         </a>
         ). Epidermolysis bullosa is broadly classified into four groups, based upon the level at which the blisters form. These are epidermolysis bullosa simplex, junctional epidermolysis bullosa, dystrophic epidermolysis bullosa, and Kindler epidermolysis bullosa. The pathogenesis, clinical manifestations, diagnosis, and management of epidermolysis bullosa and Kindler epidermolysis bullosa are discussed in detail separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">
          "Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15452.html" rel="external">
          "Diagnosis of epidermolysis bullosa"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15453.html" rel="external">
          "Overview of the management of epidermolysis bullosa"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15510.html" rel="external">
          "Kindler epidermolysis bullosa"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1181776286">
         <span class="h2">
          Bullous dermolysis of the newborn
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bullous dermolysis of the newborn, previously called transient bullous dermolysis of the newborn, is a subtype of dystrophic epidermolysis bullosa characterized by skin fragility and blister formation at birth that typically improves or resolves within the first year of life  (
         <a class="graphic graphic_picture graphicRef115799" href="/z/d/graphic/115799.html" rel="external">
          picture 31
         </a>
         ) [
         <a href="#rid73">
          73,74
         </a>
         ]. Milia, atrophic scarring, and nail dystrophy can persist [
         <a href="#rid75">
          75
         </a>
         ]. Ultrastructurally, bullous dermolysis of the newborn shares the characteristic findings of dystrophic epidermolysis bullosa, namely a split below the level of the lamina densa; disruption of anchoring fibrils; and presence of electron-dense stellate or rod-like bodies within the dilated, rough, endoplasmic reticulum of basal keratinocytes. On immunofluorescence microscopy, intracytoplasmic, epidermal inclusions of C7 appear to be a unique characteristic of bullous dermolysis of the newborn [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4157089698">
         <span class="h2">
          Autoimmune bullous diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pemphigus and bullous pemphigoid are exceedingly rare in infants [
         <a href="#rid76">
          76,77
         </a>
         ]. In most cases, they present at birth with vesicles, blisters, or erosions. The most frequently involved sites are (in decreasing order) the trunk, head and neck, and acral areas. Mucous membranes are affected in approximately 30 to 40 percent of cases [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Epidermolytic ichthyosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermolytic ichthyosis, also called epidermolytic hyperkeratosis or bullous congenital ichthyosiform erythroderma, is an autosomal dominant disorder that typically presents in the neonatal period. Raw erosions and ruptured bullae are present at birth and may be misdiagnosed as epidermolysis bullosa  (
         <a class="graphic graphic_picture graphicRef90570" href="/z/d/graphic/90570.html" rel="external">
          picture 32
         </a>
         ) or staphylococcal scalded skin syndrome. A frozen section of the roof of the ruptured bullae using the "jelly roll" technique can be helpful in distinguishing these entities [
         <a href="#rid78">
          78
         </a>
         ]. Bullae, although not intact at birth, may continue to form throughout early childhood. (See
         <a class="medical medical_review" href="/z/d/html/97333.html" rel="external">
          "Keratinopathic ichthyoses", section on 'Epidermolytic ichthyosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Aplasia cutis congenita
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aplasia cutis congenita is a rare, heterogeneous group of congenital disorders characterized by focal or widespread absence of the skin [
         <a href="#rid79">
          79
         </a>
         ]. Aplasia cutis congenita can occur anywhere on the body, but the vast majority of cases occur on the scalp midline as a solitary, membranous or bullous lesion  (
         <a class="graphic graphic_picture graphicRef89935" href="/z/d/graphic/89935.html" rel="external">
          picture 5
         </a>
         ). A conspicuous collar of hair around a lesion on the scalp may indicate the presence of a structural defect in the underlying bone or central nervous system  (
         <a class="graphic graphic_picture graphicRef114481" href="/z/d/graphic/114481.html" rel="external">
          picture 33
         </a>
         ). Associated vascular stain, nodule and vertex, or midline location also increase this risk [
         <a href="#rid80">
          80
         </a>
         ]. Clinical subtypes are characterized by their location and pattern of lesions, associated malformations, and mode of inheritance [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
         The classification, diagnosis, and management of aplasia cutis congenita are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/13725.html" rel="external">
          "Aplasia cutis congenita"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Incontinentia pigmenti
         </span>
         <span class="headingEndMark">
          —
         </span>
         Incontinentia pigmenti is an X-linked, dominant, multisystem disease that is usually lethal in males in utero [
         <a href="#rid82">
          82
         </a>
         ]. Incontinentia pigmenti is caused by mutations in the
         <em>
          IKBKG/NEMO
         </em>
         gene, encoding a regulatory protein involved in the activation of genes involved in cell survival, inflammation, and immunity.
        </p>
        <p>
         In females, it classically presents with a staged, cutaneous eruption  (
         <a class="graphic graphic_table graphicRef109835" href="/z/d/graphic/109835.html" rel="external">
          table 5
         </a>
         ); variable developmental abnormalities involving the teeth, hair, and nails; and ocular and neurologic abnormalities.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In stage 1, or the vesicular stage, erythematous papules and vesicles appear in crops in linear streaks along the lines of Blaschko, usually beginning at birth or within the first few weeks of life, with each crop lasting one to two weeks  (
         <a class="graphic graphic_picture graphicRef78272" href="/z/d/graphic/78272.html" rel="external">
          picture 27B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage 2, or the verrucous stage, consists of hyperkeratotic, warty papules or plaques in linear or swirling patterns  (
         <a class="graphic graphic_picture graphicRef53297" href="/z/d/graphic/53297.html" rel="external">
          picture 34
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage 3, or the pigmented stage, presents as streaks of hyperpigmentation in a "marble cake pattern"  (
         <a class="graphic graphic_picture graphicRef63009" href="/z/d/graphic/63009.html" rel="external">
          picture 35
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage 4, or the final stage, where the hyperpigmented streaks may evolve into hypopigmented and atrophic patches or streaks.
        </p>
        <p>
        </p>
        <p>
         All stages may be present simultaneously and may occur in utero. The clinical features, diagnosis, and management of incontinentia pigmenti are discussed in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15513.html" rel="external">
          "Incontinentia pigmenti"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Cutaneous mastocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cutaneous mastocytosis is an infiltrative skin disorder that can present with vesicles and blisters in the newborn  (
         <a class="graphic graphic_picture graphicRef52257 graphicRef115803" href="/z/d/graphic/52257.html" rel="external">
          picture 36A-B
         </a>
         ). The two main forms are cutaneous mastocytomas, which present with solitary or multiple erythematous nodules, and maculopapular cutaneous mastocytosis (previously called urticaria pigmentosa), which presents with multiple monomorphic, reddish-brown macules and papules anywhere on the body (except the palms and soles)  (
         <a class="graphic graphic_picture graphicRef115803" href="/z/d/graphic/115803.html" rel="external">
          picture 36B
         </a>
         ). Both forms of cutaneous mastocytosis may present with bullous lesions in infants. (See
         <a class="medical medical_review" href="/z/d/html/103161.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in children: Epidemiology, clinical manifestations, evaluation, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benign and self-limited disorders
         </strong>
         – Benign and self-limited vesiculopustular disorders in the newborn may present as generalized eruptions (eg, erythema toxicum neonatorum  (
         <a class="graphic graphic_picture graphicRef70785" href="/z/d/graphic/70785.html" rel="external">
          picture 1A
         </a>
         ), transient neonatal pustular melanosis  (
         <a class="graphic graphic_picture graphicRef59397 graphicRef64567" href="/z/d/graphic/59397.html" rel="external">
          picture 2C-D
         </a>
         ), miliaria  (
         <a class="graphic graphic_picture graphicRef102847" href="/z/d/graphic/102847.html" rel="external">
          picture 7B
         </a>
         )) or localized eruptions (eg, neonatal cephalic pustulosis, infantile acropustulosis, infantile acne). In most cases, these disorders resolve spontaneously and do not require specific therapy. (See
         <a class="local">
          'Benign vesiculopustular eruptions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infections/infestations
         </strong>
         – Common infections causing vesiculopustular eruptions include neonatal herpes simplex virus infection, neonatal varicella-zoster virus infection  (
         <a class="graphic graphic_picture graphicRef115779" href="/z/d/graphic/115779.html" rel="external">
          picture 19
         </a>
         ), staphylococcal pustulosis  (
         <a class="graphic graphic_picture graphicRef107272" href="/z/d/graphic/107272.html" rel="external">
          picture 20
         </a>
         ), and staphylococcal scalded skin syndrome  (
         <a class="graphic graphic_picture graphicRef72261 graphicRef121041" href="/z/d/graphic/72261.html" rel="external">
          picture 21A-B
         </a>
         ). Erythematous patches, papules, and pustules in intertriginous areas may occur in neonatal candidiasis  (
         <a class="graphic graphic_picture graphicRef115797 graphicRef59361" href="/z/d/graphic/115797.html" rel="external">
          picture 25A-B
         </a>
         ). Scabies is a common cause of acral vesiculopustular eruption, especially in resource-limited regions  (
         <a class="graphic graphic_picture graphicRef115804 graphicRef78272" href="/z/d/graphic/115804.html" rel="external">
          picture 27A-B
         </a>
         ). (See
         <a class="local">
          'Infectious vesiculopustular eruptions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital/inherited disorders
         </strong>
         – Several rare, inherited conditions may present with bullous lesions in the newborn. These include epidermolysis bullosa, epidermolytic ichthyosis, aplasia cutis congenita, and incontinentia pigmenti. (See
         <a class="local">
          'Congenital/inherited disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Principles of diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A thorough clinical history and physical examination in most cases provide important clues for diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The possibility of a viral, bacterial, or fungal infection should always be considered.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vesicular lesions following the lines of Blaschko on a newborn infant suggest the possibility of incontinentia pigmenti, a rare, X-linked dominant disorder  (
         <a class="graphic graphic_picture graphicRef78272" href="/z/d/graphic/78272.html" rel="external">
          picture 27B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An erosive patch or blister-like lesion on the scalp or another area of the body at birth may occur due to a local absence of skin called aplasia cutis congenita  (
         <a class="graphic graphic_picture graphicRef89935" href="/z/d/graphic/89935.html" rel="external">
          picture 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Features that suggest a potentially severe or life-threatening disease include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Widespread erythema and blistering
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vital sign abnormalities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Associated anomalies
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Poor growth
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In such cases, diagnostic testing should be pursued, and the infant should be closely monitored when there is uncertainty and when infectious, severe, or life-threatening etiologies are on the differential diagnosis in a young infant. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2443800806">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Josie A Pielop, MD, and Renee M Howard, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Reginatto FP, Muller FM, Peruzzo J, Cestari TF. Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study. Pediatr Dermatol 2017; 34:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haveri FT, Inamadar AC. A cross-sectional prospective study of cutaneous lesions in newborn. ISRN Dermatol 2014; 2014:360590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monteagudo B, Labandeira J, Cabanillas M, et al. Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors. Pediatr Dermatol 2012; 29:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reginatto FP, DeVilla D, Muller FM, et al. Prevalence and characterization of neonatal skin disorders in the first 72h of life. J Pediatr (Rio J) 2017; 93:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchini G, Nelson A, Edner J, et al. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant. Pediatr Res 2005; 58:613.
          </a>
         </li>
         <li class="breakAll">
          Paller AS, Mancini AJ. Cutaneous disorders of the newborn. In: Hurwitz Clinical Pediatric Dermatology, 5th ed, Elsevier Saunders, 2016. p.16.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carr JA, Hodgman JE, Freedman RI, Levan NE. Relationship between toxic erythema and infant maturity. Am J Dis Child 1966; 112:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berg FJ, Solomon LM. Erythema neonatorum toxicum. Arch Dis Child 1987; 62:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramamurthy RS, Reveri M, Esterly NB, et al. Transient neonatal pustular melanosis. J Pediatr 1976; 88:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barr RJ, Globerman LM, Werber FA. Transient neonatal pustular melanosis. Int J Dermatol 1979; 18:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor NR, McLaughlin MR, Ham P. Newborn skin: Part I. Common rashes. Am Fam Physician 2008; 77:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng E, Janniger CK. Miliaria. Cutis 1995; 55:213.
          </a>
         </li>
         <li class="breakAll">
          Hoath SB, Narendran V. The skin. In: Neonatal-Perinatal Medicine, 9th ed, Fanaroff AA, Martin RJ, Walsh MC (Eds), Elsevier Mosby, 2011. p.1705.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernández-Martín Á, Nuño-González A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol 2013; 68:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niamba P, Weill FX, Sarlangue J, et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 1998; 134:995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002; 138:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007; 57:1012.
          </a>
         </li>
         <li class="breakAll">
          Lucky AW. Transient benign cutaneous lesions in the newborn. In: Neonatal Dermatology, 2nd ed, Eichenfield LF, Frieden IJ, Esterly NB (Eds), Saunders, 2008. p.90.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol 1999; 38:128.
          </a>
         </li>
         <li class="breakAll">
          Paller AS, Mancini AJ. Disorders of the sebaceous and sweat glands. In: Hurwitz Clinical Pediatric Dermatology, 5th ed, Elsevier Saunders, 2015.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rapelanoro R, Mortureux P, Couprie B, et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131 Suppl 3:S163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serna-Tamayo C, Janniger CK, Micali G, Schwartz RA. Neonatal and infantile acne vulgaris: an update. Cutis 2014; 94:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Humeau S, Bureau B, Litoux P, Stalder JF. Infantile acropustulosis in six immigrant children. Pediatr Dermatol 1995; 12:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol 1998; 15:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Praag MC, Van Rooij RW, Folkers E, et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol 1997; 14:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vignon-Pennamen MD, Wallach D. Infantile acropustulosis. A clinicopathologic study of six cases. Arch Dermatol 1986; 122:1155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dromy R, Raz A, Metzker A. Infantile acropustulosis. Pediatr Dermatol 1991; 8:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bundino S, Zina AM, Ubertalli S. Infantile acropustulosis. Dermatologica 1982; 165:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol 1979; 115:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Findlay RF, Odom RB. Infantile acropustulosis. Am J Dis Child 1983; 137:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferreira S, Machado S, Selores M. INFANTILE ACROPUSTULOSIS. J Paediatr Child Health 2020; 56:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narvaez-Rosales V, de-Ocariz MS, Carrasco-Daza D, et al. Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases. Int J Dermatol 2013; 52:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piersigilli F, Diociaiuti A, Boldrini R, et al. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders. Cutis 2010; 85:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uhara H, Shiohara M, Baba A, et al. Transient myeloproliferative disorder with vesiculopustular eruption: Early smear is useful for quick diagnosis. J Am Acad Dermatol 2009; 60:869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manice CS, Planet PJ, Chase HS, Lauren CT. Management of afebrile neonates with pustules and vesicles in a pediatric emergency department. Pediatr Dermatol 2018; 35:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James SH, Kimberlin DW. Neonatal Herpes Simplex Virus Infection. Infect Dis Clin North Am 2015; 29:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curfman AL, Glissmeyer EW, Ahmad FA, et al. Initial Presentation of Neonatal Herpes Simplex Virus Infection. J Pediatr 2016; 172:121.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Herpes simplex. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.407.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001; 21:545.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Varicella-zoster virus infections. In: Red Book 2018: Report of the Committee on Infectious Diseases, 31st Edition, American Academy of Pediatrics, 2018. p.6869.
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Varicella-zoster virus infection. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.831.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aguilera-Alonso D, Alonso-Cadenas JA, Roguera-Sopena M, et al. Monkeypox virus infections in children in Spain during the first months of the 2022 outbreak. Lancet Child Adolesc Health 2022; 6:e22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramnarayan P, Mitting R, Whittaker E, et al. Neonatal Monkeypox Virus Infection. N Engl J Med 2022; 387:1618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saunders KE, Van Horn AN, Medlin HK, et al. Monkeypox in a Young Infant - Florida, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mishra AK, Yadav P, Mishra A. A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. Open Microbiol J 2016; 10:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pimentel de Araujo F, Tinelli M, Battisti A, et al. An outbreak of skin infections in neonates due to a Staphylococcus aureus strain producing the exfoliative toxin A. Infection 2018; 46:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 2003; 4:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elias PM, Fritsch P, Epstein EH. Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol 1977; 113:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honig PJ, Gaisin A, Buck BE. Frozen section differentiation of drug-induced and staphylococcal-induced toxic epidermal necrolysis. J Pediatr 1978; 92:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ito Y, Funabashi Yoh M, Toda K, et al. Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus. J Infect Chemother 2002; 8:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chi CY, Wang SM, Lin HC, Liu CC. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis 2006; 42:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kline A, O'Donnell E. Group B streptococcus as a cause of neonatal bullous skin lesions. Pediatr Infect Dis J 1993; 12:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charlier C, Kermorvant-Duchemin E, Perrodeau E, et al. Neonatal Listeriosis Presentation and Outcome: A Prospective Study of 189 Cases. Clin Infect Dis 2022; 74:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith KJ, Yeager J, Skelton HG 3rd, Angritt P. Diffuse petechial pustular lesions in a newborn. Disseminated Listeria monocytogenes. Arch Dermatol 1994; 130:245, 248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith KJ, Skelton HG 3rd, Angritt P, et al. Cutaneous lesions of listeriosis in a newborn. J Cutan Pathol 1991; 18:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz KA. Congenital Syphilis-Still a Shadow on the Land. JAMA Dermatol 2018; 154:1389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorfman DH, Glaser JH. Congenital syphilis presenting in infants after the newborn period. N Engl J Med 1990; 323:1299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowen JL, Atkins JT, Levy ML, et al. Invasive fungal dermatitis in the &lt; or = 1000-gram neonate. Pediatrics 1995; 95:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perzigian RW, Faix RG. Primary cutaneous aspergillosis in a preterm infant. Am J Perinatol 1993; 10:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nanda S, Reddy BS, Ramji S, Pandhi D. Analytical study of pustular eruptions in neonates. Pediatr Dermatol 2002; 19:210.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Scabies. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quarterman MJ, Lesher JL Jr. Neonatal scabies treated with permethrin 5% cream. Pediatr Dermatol 1994; 11:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill TA, Cohen B. Scabies in babies. Pediatr Dermatol 2017; 34:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126:226.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Scabies. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.663.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas C, Coates SJ, Engelman D, et al. Ectoparasites: Scabies. J Am Acad Dermatol 2020; 82:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adam R, Schroten H. Picture of the month. Congenital sucking blisters. Arch Pediatr Adolesc Med 2007; 161:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tlougan BE, Paller AS, Schaffer JV, et al. Congenital erosive and vesicular dermatosis with reticulated supple scarring: unifying clinical features. J Am Acad Dermatol 2013; 69:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong V, Fischer G. Congenital erosive and vesicular dermatosis with reticulated supple scarring. Australas J Dermatol 2017; 58:e236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shope C, Cotton CH, Wine Lee L. Congenital erosive and vesicular dermatosis healing with reticulated and supple scarring: Two cases secondary to fungal infection. Pediatr Dermatol 2023; 40:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Védie AL, Gan E, Belivier E, et al. Congenital erosive and vesicular dermatosis associated with herpes simplex virus. J Eur Acad Dermatol Venereol 2016; 30:e156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heinecke G, Marinkovich MP, Rieger KE. Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn. Pediatr Dermatol 2017; 34:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radkevich-Brown O, Shwayder T. Bullous dermolysis of the newborn: four new cases and clinical review. Pediatr Dermatol 2013; 30:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diociaiuti A, Castiglia D, Giancristoforo S, et al. Frequent Occurrence of Aplasia Cutis Congenita in Bullous Dermolysis of the Newborn. Acta Derm Venereol 2016; 96:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwieger-Briel A, Moellmann C, Mattulat B, et al. Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis 2014; 9:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao CY, Chiang YZ, Murrell DF. Neonatal Autoimmune Blistering Disease: A Systematic Review. Pediatr Dermatol 2016; 33:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galler B, Bowen C, Arnold J, et al. Use of the frozen section 'jelly-roll' technique to aid in the diagnosis of bullous congenital ichthyosiform erythroderma (epidermolytic hyperkeratosis). J Cutan Pathol 2016; 43:434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bharti G, Groves L, David LR, et al. Aplasia cutis congenita: clinical management of a rare congenital anomaly. J Craniofac Surg 2011; 22:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel DP, Castelo-Soccio L, Yan AC. Aplasia cutis congenita: Evaluation of signs suggesting extracutaneous involvement. Pediatr Dermatol 2018; 35:e59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol 1986; 14:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swinney CC, Han DP, Karth PA. Incontinentia Pigmenti: A Comprehensive Review and Update. Ophthalmic Surg Lasers Imaging Retina 2015; 46:650.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5790 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28543629" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24575304" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A cross-sectional prospective study of cutaneous lesions in newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22066938" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27875703" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prevalence and characterization of neonatal skin disorders in the first 72h of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16148082" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16148082" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5947490" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Relationship between toxic erythema and infant maturity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3592724" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Erythema neonatorum toxicum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1271148" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Transient neonatal pustular melanosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/511427" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Transient neonatal pustular melanosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18236822" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Newborn skin: Part I. Common rashes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7796612" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Miliaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7796612" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Miliaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22819356" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9722730" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11843642" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17889963" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17889963" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10192162" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Acne neonatorum: a study of 22 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10192162" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Acne neonatorum: a study of 22 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8629828" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Neonatal Malassezia furfur pustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23637225" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Evidence-based recommendations for the diagnosis and treatment of pediatric acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25101339" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Neonatal and infantile acne vulgaris: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7501548" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Infantile acropustulosis in six immigrant children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9796580" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9144701" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Diagnosis and treatment of pustular disorders in the neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2429621" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Infantile acropustulosis. A clinicopathologic study of six cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1792199" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Infantile acropustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6762976" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Infantile acropustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/156521" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Acropustulosis of infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6342363" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Infantile acropustulosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32725735" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : INFANTILE ACROPUSTULOSIS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23046498" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20666188" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19389530" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Transient myeloproliferative disorder with vesiculopustular eruption: Early smear is useful for quick diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29974501" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Management of afebrile neonates with pustules and vesicles in a pediatric emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26154662" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Neonatal Herpes Simplex Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26960921" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Initial Presentation of Neonatal Herpes Simplex Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26960921" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Initial Presentation of Neonatal Herpes Simplex Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11774017" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Neonatal varicella.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11774017" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Neonatal varicella.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11774017" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Neonatal varicella.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36058226" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Monkeypox virus infections in children in Spain during the first months of the 2022 outbreak.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36223535" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Neonatal Monkeypox Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36136958" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Monkeypox in a Young Infant - Florida, 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27651848" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29110142" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : An outbreak of skin infections in neonates due to a Staphylococcus aureus strain producing the exfoliative toxin A.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12627992" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Staphylococcal scalded skin syndrome: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/836697" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/633001" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Frozen section differentiation of drug-induced and staphylococcal-induced toxic epidermal necrolysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12373491" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16355327" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8426780" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Group B streptococcus as a cause of neonatal bullous skin lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33876229" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Neonatal Listeriosis Presentation and Outcome: A Prospective Study of 189 Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8304768" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Diffuse petechial pustular lesions in a newborn. Disseminated Listeria monocytogenes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1774359" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Cutaneous lesions of listeriosis in a newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30193335" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Congenital Syphilis-Still a Shadow on the Land.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2215616" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Congenital syphilis presenting in infants after the newborn period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7724303" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Invasive fungal dermatitis in the&lt;or = 1000-gram neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8397559" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Primary cutaneous aspergillosis in a preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12047639" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Analytical study of pustular eruptions in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12047639" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Analytical study of pustular eruptions in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7971563" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Neonatal scabies treated with permethrin 5% cream.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28833468" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Scabies in babies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4125053" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Scabies in babies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4125053" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Scabies in babies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31310840" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Ectoparasites: Scabies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17548768" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Picture of the month. Congenital sucking blisters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24099729" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Congenital erosive and vesicular dermatosis with reticulated supple scarring: unifying clinical features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28247410" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Congenital erosive and vesicular dermatosis with reticulated supple scarring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36813738" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Congenital erosive and vesicular dermatosis healing with reticulated and supple scarring: Two cases secondary to fungal infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26537443" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Congenital erosive and vesicular dermatosis associated with herpes simplex virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28523885" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24117545" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Bullous dermolysis of the newborn: four new cases and clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26864810" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Frequent Occurrence of Aplasia Cutis Congenita in Bullous Dermolysis of the Newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25491396" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Bullous pemphigoid in infants: characteristics, diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27086740" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Neonatal Autoimmune Blistering Disease: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26969483" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Use of the frozen section 'jelly-roll' technique to aid in the diagnosis of bullous congenital ichthyosiform erythroderma (epidermolytic hyperkeratosis).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21187755" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Aplasia cutis congenita: clinical management of a rare congenital anomaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29178194" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Aplasia cutis congenita: Evaluation of signs suggesting extracutaneous involvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3514708" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Aplasia cutis congenita: a clinical review and proposal for classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26114846" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Incontinentia Pigmenti: A Comprehensive Review and Update.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
